These findings suggest that the therapeutic effect of SFN on IMQ-induced mice is primarily dependent on NRF2 activation, and that NRF2 deletion exacerbates psoriasis-like skin lesions (Fig. 9). Here, NFE2L2 is linked to psoriasis.